您的位置: 首页 > 农业专利 > 详情页

Glucan-encapsulated siRNA for treating type 2 diabetes mellitus
专利权人:
The United States of America, as represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES;UNIVERSITY OF MASSACHUSETTS
发明人:
George Kunos,Tony Jourdan,Michael Paul Czech,Myriam Aouadi
申请号:
US14900951
公开号:
US10077446B2
申请日:
2014.06.24
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Compositions comprising glucan-encapsulated siRNA directed against a region of the gene encoding the human CB1 receptor for use in the treatment of type 2 diabetes mellitus in a human subject. Additionally, methods for treating type 2 diabetes mellitus in a subject, comprising administering to the subject a composition comprising glucan-encapsulated siRNA directed against the CB1 receptor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充